Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury
Experimental Biology and Medicine · 2025
DOI: 10.3389/ebm.2025.10782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Ane Caroline Ribeiro Novaes Martins und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Research Laboratory, Histology and Embryology Department, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Acute Lung Injury, Mesenchymal Stem Cells, Liver Cirrhosis, Secretome. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Chronic liver disease (CLD) is a widespread condition and liver fibrosis is a common hallmark. The COVID-19 pandemic has drawn awareness over emerging pathogens that pose severe risks for chronic disease patients, whose management is complicated because most drugs can overload liver metabolism, therefore therapeutic alternatives are needed. Aims: based on the difficulty of treating CLD patients during respiratory infections, this study focused on the therapeutic evaluation of adipose-derived mesenchymal stromal cell (ASC) secretome. Methods: the effects of ASC secretome were evaluated in a preclinical murine model of liver fibrosis induced by thioacetamide (TAA) and acute lung injury induced by lipopolysaccharide, using histological and cytokine profile analyses. ASC secretome exhibited therapeutic effects alleviating fibrogenesis and inflammation, decreasing plasmatic inflammatory markers (cytokines IL-6, IL-17A and TNF-α), and restoring immune homeostasis. The secretome reduced liver collagen accumulation and IL-6 levels and restored lung cytoarchitecture, decreasing levels of CD68 and TNF-α. These results provide a preclinical basis for potential clinical use of the ASC secretome and its products, advancing the concept of cell-free, systemically active interventions for complex tissue injuries, and reinforcing the potential of its paracrine factors to modify pathological responses and promote tissue regeneration in combined chronic-acute diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell Research Laboratory, Histology and Embryology Department, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
- Post-Graduation Program in Clinical and Experimental Pathophysiology (FISCLINEX), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
- Ultrastructure and Tissue Biology Laboratory, Histology and Embryology Department, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Martins, A. C. R. N., Silva, K. R., Pereira, A. C. S., Paris, G. C., Nascimento, A. L. R., Aiceles, V., Cortez, E. A. C., Thole, A. A., & de Carvalho, S. N. (2025). Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10782
Vancouver
Martins ACRN, Silva KR, Pereira ACS, Paris GC, Nascimento ALR, Aiceles V, et al. Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10782
BibTeX
@article{Martins2025,
author = {Martins, Ane Caroline Ribeiro Novaes and Silva, Karina Ribeiro and Pereira, Anna Carolina de Souza and Paris, Gustavo Claudino and Nascimento, Ana Lúcia Rosa and Aiceles, Verônica and Cortez, Erika Afonso Costa and Thole, Alessandra Alves and de Carvalho, Simone Nunes},
title = {Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury},
journal = {Experimental Biology and Medicine},
year = {2025},
doi = {10.3389/ebm.2025.10782}
}
EUVIMED